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OBJECTIVES We sought to determine the importance of chest pain on presentation as a predictor of
in-hospital treatment and mortality in myocardial infarction (MI) patients with left
bundle-branch block (LBBB).
BACKGROUND Left bundle-branch block patients have a high mortality after MI but are unlikely to receive
reperfusion therapy despite evidence from clinical trials demonstrating the efficacy of
thrombolytic therapy. Nearly half of MI patients with LBBB present without chest pain.
METHODS We studied the clinical features, treatment and in-hospital survival of 29,585 patients with
LBBB enrolled in the National Registry of MI 2 (June 1994 through March 1998).
Multivariate logistic regression was used to assess the independent effect of chest pain on
reperfusion decisions and in-hospital mortality.
RESULTS Left bundle-branch block patients with chest pain were greater than five-fold more likely to
receive reperfusion therapy (13.6% vs. 2.6%) than LBBB patients without chest pain; they
were also more likely to receive aspirin, beta-adrenergic blocking agents, heparin and nitrates
(all p , 0.0001). Unadjusted in-hospital mortality was 18% in patients with chest pain and
27% in patients without chest pain. Adjusting for patient characteristics reduced the odds
ratio associated with the absence of chest pain from 1.47 (95% confidence interval: 1.41 to
1.54) to 1.21 (95% confidence interval: 1.12 to 1.30). The remainder of the mortality
difference was caused by the undertreatment of patients without chest pain, particularly the
low utilization of aspirin and beta-blockers.
CONCLUSIONS Left bundle-branch block patients with MI who present without chest pain are less likely to
receive optimal therapy and are at increased risk of death. Prompt recognition and treatment
of this high-risk subgroup should improve survival. (J Am Coll Cardiol 2000;36:706–12) ©
2000 by the American College of Cardiology
Patients with myocardial infarction (MI) who present with
left bundle-branch block (LBBB) have greater in-hospital
mortality (22.6%) than patients without LBBB (13.1%) yet
are less likely to receive medications or interventions known
to improve survival (1–7). Physicians are especially reluctant
to utilize reperfusion therapy (thrombolytic therapy or
primary angioplasty) in patients with LBBB (3,8). The
reason given by physicians for not utilizing reperfusion in
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LBBB patients with MI was “nondiagnostic electrocardio-
gram (ECG)” in over half of the patients denied treatment
(5). A recent study confirmed that the ECG is indeed
unable to distinguish effectively MI from other diagnoses
among symptomatic patients with LBBB (9). This inability
to diagnose MI reliably in LBBB patients with the ECG
results in delays in the recognition of the infarction and
inhibits the delivery of optimal care. Furthermore, the
insensitivity of the ECG criteria that have been proposed
for patients with LBBB may give clinicians a false sense of
security toward the LBBB patient with MI whose ECG
does not fit the criteria (10,11).
The challenge of appropriately recognizing MI in pa-
tients with LBBB, who represent about 7% of patients with
MI in a sample from the National Registry of MI 2 (NRMI
2), may be increased by the frequency with which they
present with atypical symptoms (5). Left bundle-branch
block patients with MI are older (76 vs. 68 years) and more
likely to be women (50% vs. 41%) than patients with MI
and without LBBB, and they have a higher prevalence of
diabetes (36% vs. 26%)—all characteristics associated with
an atypical presentation of MI (12–15). A recent study from
NRMI 2 demonstrated that nearly half of LBBB patients
with MI presented to medical attention without chest pain
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(compared with 30% of MI patients without LBBB) but did
not address potential differences in treatment or survival in
this subgroup (5).
Because appropriate therapy for MI begins with prompt
recognition and intervention, we hypothesized that patients
with LBBB who present without chest pain might be at
even greater risk of undertreatment. These patients without
chest pain may also have greater mortality than LBBB
patients with chest pain, as a result of undertreatment.
Using data collected in NRMI 2, which included 29,585
patients with LBBB, we compared presenting characteris-
tics, admitting diagnosis, treatment and outcomes among
LBBB patients with MI who presented with and without
chest pain.
METHODS
Subjects. The NRMI 2 is a voluntary, prospective obser-
vational registry of patients admitted to over 1,470 hospitals
in all 50 states in the U.S. The registry includes only
patients with the diagnosis of MI and records data on
in-hospital events. Our data set included 772,586 patients
admitted from June 1994 to March 1998. Patients who were
transferred to or from another acute care facility were
excluded due to the absence of presenting characteristics or
in-hospital outcomes. The diagnosis of MI required a
presentation of cardiopulmonary symptoms or signs and at
least one of the following: 1) total creatine kinase or creatine
kinase myocardial isoenzymes at least twice the upper limit
of the normal range, 2) ECG evidence of MI, 3) alternative
enzymatic, scintigraphic or autopsy evidence of MI, or 4) a
principal discharge diagnosis of MI (code 410.X1, Interna-
tional Classification of Diseases, 9th Revision, Clinical
Modification). The initial ECG report included responses
indicating the presence of right bundle-branch block or
LBBB. The actual ECGs are not obtainable in the NRMI
2 registry. This study includes the 29,585 patients with
LBBB on the initial ECG.
Data collection. Data on each patient included in the
registry are abstracted by a trained registry coordinator at
each participating hospital and recorded on standardized
case report forms. An independent central data collection
center (ClinTrials, Inc., Lexington, Kentucky) processed
the data using double-key data entry and multiple electronic
data checks to ensure accuracy, consistency and complete-
ness. Errors in case report forms were resolved before
inclusion into the database (16).
Measurements. Chest pain was defined as discomfort or
pressure in the chest, arm or jaw; it was characterized as
either present or absent on presentation. The presence or
absence of other presenting symptoms, such as dyspnea,
nausea/vomiting or palpitations, was not recorded. Other
recorded variables include age, sex, race/ethnicity (white,
black or other/unknown), cardiac risk factors (diabetes,
hypertension, current tobacco use, family history of coro-
nary heart disease or hypercholesterolemia), cardiovascular
history (prior MI, angina, congestive heart failure, stroke,
percutaneous transluminal coronary angioplasty [PTCA],
coronary artery bypass graft surgery [CABG]), severity of
presentation (initial heart rate, blood pressure, Killip class,
MI location), admission diagnosis and hospital bed type,
medications and procedures utilized in-hospital and at
discharge, ejection fraction (if measured), adverse events
during hospitalization (hypotension, heart failure, cardio-
genic shock, recurrent ischemia and infarction) and length
of hospital stay.
Outcomes of this analysis were divided into treatment
measures and mortality. We considered initial reperfusion
therapy strategy to include intravenous thrombolytic
therapy, primary PTCA, intracoronary thrombolytic ther-
apy or immediate CABG. We also compared utilization
of medications (aspirin, beta-adrenergic blocking agents,
angiotensin-converting enzyme [ACE] inhibitors, heparin,
nitrates and calcium channel blockers) in the first 24 h and
in-hospital revascularization procedures (CABG and
PTCA). In-hospital mortality was the primary health-
related outcome of this study.
Statistical analysis. Bivariate comparisons of the differ-
ences in demographic and clinical characteristics, diagnoses
and treatments given and in-hospital mortality of LBBB
patients with and without chest pain were made using
chi-square tests for categorical variables, t tests for contin-
uous variables and nonparametric methods for continuous
variables that were not normally distributed.
The association between the absence of chest pain and
receipt of initial reperfusion therapy, independent of other
patient characteristics, was evaluated using multivariate
logistic regression. A forward stepwise procedure was used
including variables with an independent association with
reperfusion therapy at a p , 0.05 significance level.
To evaluate the independent association of absence of
chest pain with in-hospital mortality, we conducted logistic
regression modeling in several stages. Model 1 adjusted for
demographic and comorbidity characteristics of the patients
before hospital admission (age, gender, race, prior cardio-
vascular history and prior medical history). In Model 2, we
also adjusted for characteristics of the patient’s clinical
presentation, including vital signs, Killip class and admitting
diagnosis. In Model 3 we added hospital bed assignment
and treatments given in-hospital, including medications and
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selected cardiac procedures. Statistical significance was de-
termined by a two-sided p value ,0.05.
RESULTS
Baseline characteristics of LBBB patients with and with-
out chest pain at presentation. Of the 29,585 patients
with LBBB and MI in the NRMI-2 registry, 15,713 (53%)
reported chest pain at presentation, and 13,872 (47%) did
not report chest pain. Patients with chest pain were younger
and more likely to be male than patients without chest pain
(Table 1). Race was similar in the two groups of patients.
Patients with chest pain were more likely to have a prior
history of cardiovascular events, including MI, angina,
PTCA and CABG. Patients without chest pain were more
likely to have a history of congestive heart failure. The two
groups of patients had similar rates of prior stroke, diabetes,
hypertension and current tobacco use. Patients with chest
pain were more likely to have a family history of coronary
heart disease and hypercholesterolemia.
Although we lack information on the exact symptoms of
the patients without chest pain, at least 65% had clinical
heart failure, based on a Killip class .1 (Table 1). Com-
pared with patients with chest pain, these patients were less
likely to be Killip class 1 (51% vs. 35%) and more likely to
be Killip class 3 and 4 (19% vs. 32%). The patients with
chest pain had significantly higher systolic and diastolic
blood pressure and lower heart rate.
Initial diagnosis and hospital bed assignment. Myocar-
dial infarction was the admitting diagnosis for a small
proportion (20%) of the LBBB patients with MI (Table 2).
However, the proportion diagnosed accurately at admission
was higher for patients with chest pain (25%) than for those
without chest pain (14%). The diagnosis of “unstable
angina” or “rule-out MI” was given at admission to 56% of
the patients with chest pain, but only 27% without chest
pain. The initial diagnosis was “other” for 59% of MI
patients with LBBB who did not have chest pain, but only
19% of the patients with chest pain.
Despite the imprecision of the initial diagnosis, the vast
majority of patients were admitted to intensive care or
telemetry units. However, 9% of patients without chest pain
were admitted to wards without cardiac monitoring,
whereas only 1% of the patients with chest pain were
admitted to unmonitored beds.
Table 1. Characteristics of 29,585 Patients With Left Bundle Branch Block and Myocardial In-
farction at Presentation in the National Registry for Myocardial Infarction 2 (June 1,
1994–March 31, 1998)
Characteristic*
Patients
With Chest
Pain
(n 5 15,713)
Patients Without
Chest Pain
(n 5 13,872)
Mean age (yr) 75 78
Female gender (%) 47 52
Race (%)
White 91 90
Black 6 6
Other or unknown 4 4
Medical history (%)
Previous myocardial infarction 42 34
Angina 30 18
Congestive heart failure 36 45
Previous PTCA 9 5
Previous CABG 22 14
Previous stroke 12 15
Diabetes mellitus 36 38
Hypertension 57 55
Current smoker 13 12
Family history of heart disease 22 16
Hypercholesterolemia 21 14
Clinical presentation
Mean body weight at admission 163 156
Mean systolic blood pressure 144 137
Mean diastolic blood pressure 80 75
Mean heart rate at admission 95 100
Killip class for congestive heart failure (%)
1: No congestive heart failure 51 35
2: Rales, jugular venous distension 30 34
3: Pulmonary edema 17 29
4: Cardiogenic shock 2 3
*p value 5 0.04 for association of race and chest pain; p value , 0.01 for association of chest pain and history of hypertension
and diabetes; for all other associations, p value , 0.0001.
CABG 5 coronary artery bypass graft surgery; PTCA 5 percutaneous transluminal coronary angioplasty.
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In-hospital treatment of LBBB patients with and with-
out chest pain. Although acute reperfusion therapy was
uncommonly used in all LBBB patients with MI (8.4%
overall), patients with chest pain were over four-fold more
likely to be treated (Table 3). Even among the patients
presenting within 12 h of the onset of chest pain who did
not have contraindications to thrombolytic therapy (ideal
candidates for reperfusion therapy), only 17% were reper-
fused. The reasons given by physicians for not utilizing
reperfusion were similar for the two groups of patients. The
primary explanation in both groups (57% overall) was
“nondiagnostic ECG.”
Left bundle-branch block patients who presented with
chest pain were also more likely to receive appropriate
medical treatment within the initial 24 h after admission
(Table 3). Aspirin, beta-blockers, intravenous nitroglycerin
and heparin were all more commonly administered to
patients with chest pain. Utilization of ACE-inhibitors and
calcium channel blockers was similar in the two groups.
Patients with chest pain were more than twice as likely to
receive coronary angiography, PTCA or CABG in-hospital.
Using multivariate logistic regression, we evaluated the
independent association of the presence of chest pain as a
predictor of reperfusion therapy in patients with LBBB.
After adjusting for presenting characteristics and admitting
diagnosis, patients without chest pain were four times less
likely to receive reperfusion therapy (odds ratio [OR] 0.25;
0.22 to 0.29). Characteristics associated with an increased
likelihood of reperfusion included previous PTCA, increas-
ing body weight and prior diagnosis of hypercholesterol-
emia. Patient characteristics negatively associated with
reperfusion were increasing age; female gender; black race;
diabetes; prior history of MI, angina, CABG and stroke;
and increased heart rate. Admission diagnosis of MI was
highly associated with reperfusion; the adjusted ORs for not
being reperfused ranged from 7.2 to 10.8 for patients
admitted with other diagnoses. This association indicates
that early diagnosis of MI led to increased reperfusion
therapy.
Table 3. Comparison of Treatments Received by 29,585 Patients With Acute MI and LBBB
With and Without Chest Pain in the National Registry for Myocardial Infarction 2 (June 1,
1994–March 31, 1998)
Patients
With Chest
Pain
(n 5 15,713)
Patients Without
Chest Pain
(n 5 13,872)
Any initial reperfusion therapy (%) 13.6 2.6
Intravenous thrombolytic therapy 8.5 1.4
Primary PTCA 4.4 1.0
Other 0.6 0.2
Reason why thrombolytic therapy was not used (%)
Nondiagnostic electrocardiogram 55.9 58.4
Advanced age 9.7 9.4
Prolonged duration of symptoms 9.5 7.1
Contraindication 9.9 13.3
Other or not specified 14.1 17.1
Other medical therapies during first 24 h (%)
Aspirin 73.1 54.6
Beta-blocker 33.5 18.6
Heparin 69.3 48.4
Intravenous nitroglycerin 58.7 30.7
ACE inhibitor 29.8 32.1
Calcium-channel blocker 21.4 17.1
Other in-hospital procedures (%)
Coronary angiography 33.7 15.8
Elective PTCA 12.0 3.7
Elective CABG 6.2 3.0
*p value , 0.0001 for all comparisons between patients with and without chest pain.
ACE 5 angiotensin-converting enzyme; CABG 5 coronary artery bypass graft surgery; PTCA 5 percutaneous transluminal
coronary angioplasty.
Table 2. Comparison of Admitting Diagnosis and Initial
Hospital Bed Assignments of 29,585 Patients With LBBB and
Acute MI in the National Registry for Myocardial Infarction 2
(June 1, 1994–March 31, 1998)
Patients
With LBBB
and Chest
Pain
(n 5 15,713)
Patients With
LBBB and No
Chest Pain
(n 5 13,872)
Admitting diagnosis, %
Myocardial infarction 25 14
Rule-out myocardial
infarction
38 23
Unstable angina 18 4
Other 19 59
Admitting bed assignment, %
Intensive care unit 69 60
Monitored bed 30 31
Unmonitored bed 1 9
*p , 0.0001 for comparisons of admission diagnoses and admitting bed assignment
with presence of chest pain.
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In-hospital mortality for patients with and without chest
pain. Left bundle-branch block patients with MI who
presented without chest pain had a 47% greater in-hospital
mortality rate than patients with chest pain (27% vs. 18%;
p , 0.001) (Table 4). Causes of death, however, were
similar for the two groups of patients. The most common
reported causes of death were cardiogenic shock, arrhyth-
mias and sudden death and heart failure.
The increased risk for LBBB patients without chest pain
varied by age category (Table 5). For patients under 65 years
of age (n 5 4,101), the OR was 2.86 (95% confidence
interval [CI]: 2.43 to 3.42); for patients 65 to 75 (n 5
7,752), the OR was 1.92 (1.71 to 2.15); and, for patients
over 75 (n 5 17,705), the OR for patients without chest
pain was 1.30 (1.21 to 1.40). Thus, the risk associated with
the absence of chest pain was particularly marked for the
younger patients with lower overall mortality risk.
Chest pain as an independent predictor of mortality.
The unadjusted relative risk for mortality associated with
the absence of chest pain was 1.47 (1.41 to 1.54) (Fig. 1).
Other clinical predictors of mortality were Killip class 3 to
4 (OR 5 1.72; 95% CI: 1.58 to 1.88), Killip class 2 (1.30;
95% CI: 1.20 to 1.41) and age (OR of 1.20 per 10 year
increase; 1.15 to 1.24). Adjusting for patient demographic
characteristics and past medical history (Model 1) did not
diminish the association of chest pain absence and mortal-
ity. However, differences in the severity of the clinical
presentation among LBBB patients with and without chest
pain did confound the association with mortality. In Model
2, after adjusting for severity of illness characteristics, the
OR associated with absence of chest pain was reduced to
1.21 (1.12 to 1.30).
Differences in the treatment of patients with and without
chest pain had a large impact on survival. The treatment
variable with the largest contribution to the difference in
mortality between LBBB patients with and without chest
pain was aspirin (OR for in-hospital survival 5 0.47; 0.44 to
0.51). After adjusting for aspirin, the OR associated with
the absence of chest pain was reduced to 1.11 (1.03 to 1.19).
Other treatments affecting the association between presence
of chest pain and in-hospital survival were (in order of
effect): beta-blockers, calcium channel blockers and ACE
inhibitors. After adjustment for hospital bed assignment
and medications and procedures utilized in-hospital (Model
3), we found no significant association between the absence
of chest pain and in-hospital mortality (OR 5 1.07; 0.98 to
1.16).
DISCUSSION
New findings. Patients with LBBB have been demon-
strated to have greater in-hospital mortality after MI (4–
6,17), yet they remain severely undertreated with reperfu-
sion (3). In this study, we found that only 17% of LBBB
patients with MI presenting with chest pain who were ideal
candidates for thrombolysis received reperfusion therapy.
Table 5. In-hospital Mortality of LBBB Patients With MI Stratified by Age and the Presence
of Chest Pain
Age <65 yrs Age 65–75 yrs Age >75 yrs p Value*
Chest pain present
Number of patients 2,591 4,301 8,803
Mortality (%) 11.6 15.7 21.0 , 0.001
No chest pain
Number of patients 1,510 3,451 8,902
Mortality (%) 28.1 26.9 26.1 , 0.001
*p value by chi-square.
Table 4. Mortality Estimates and Causes of Death for Patients With LBBB Stratified by
Presence of Chest Pain in the National Registry for Myocardial Infarction 2 (June 1,
1994–March 31, 1998)
LBBB
Patients
With Chest
Pain
(n 5 15,713)
LBBB Patients
Without Chest Pain
(n 5 13,872)
Total in-hospital mortality rate (%) 18 27
Cause of death (%)*
Cardiogenic shock 34 29
Arrhythmia/cardiac arrest 31 29
Heart failure 13 13
Cardiac rupture/PEA 5 4
2nd/3rd degree heart block 2 1
Other/unknown 15 23
*These figures are the proportion of deaths due to the listed cause.
p value ,0.0001 for mortality rates. Chi-square test for the distribution of causes of mortality: p , 0.001.
LBBB 5 left bundle branch block; PEA 5 pulse less electrical activity.
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Furthermore, we identified a substantial subgroup of LBBB
patients, those without chest pain at presentation, who are
at even greater risk for undertreatment and for mortality
in-hospital.
Association with advanced age. The advanced age of
patients with LBBB and MI, both with and without chest
pain, is an important component of their increased mortality
risk. The proportion of MI patients with LBBB increases
with age, from 2.7% in patients ,65 years of age to 10.5%
in patients over 75. Elderly patients are also more likely to
present with atypical symptoms and the absence of chest
pain than nonelderly patients (15,18–21). However, the
increased risk of both LBBB and the absence of chest pain
are independent of age alone.
Other symptoms. Although the absence of chest pain was
associated with increased mortality, we are not certain what
the presenting symptoms were in these patients who com-
prised half of all MIs in LBBB patients. Since about two
thirds presented in clinical heart failure, we speculate that
the vast majority presented with dyspnea. Based on Killip
class and vital signs at admission, the MIs were more severe
in these patients than in those who presented with chest
pain.
Decreased treatment. Despite their severe presentations,
LBBB patients without chest pain were rarely admitted
with a diagnosis of MI. The absence of a diagnosis of MI in
LBBB patients without chest pain may have led them to be
under-treated with aspirin, beta-blockers, heparin and
reperfusion therapy. Not surprisingly, absence of chest pain
was one of the strongest predictors for not receiving reper-
fusion therapy among MI patients with LBBB.
Increased mortality. We observed a striking difference in
mortality between LBBB patients with and without chest
pain; patients without chest pain had a 50% greater risk of
death during hospitalization. Using staged logistic regres-
sion analyses, we demonstrated that more severe presenta-
tions of these patients were only partially responsible for the
observed differences in mortality. The under-treatment of
patients without chest pain caused the remainder of their
increased mortality. The most striking example of treatment
under-utilization is aspirin, used in less than two-thirds of
patients in this sample; yet, adjusted analyses indicated that
this inexpensive intervention reduced the odds of in-
hospital death by over 50%. Improvements in the diagnosis
and treatment of LBBB patients with MI should improve
their survival.
Implications. The results of this study should direct atten-
tion toward all patients with LBBB who present to medical
attention with acute cardiopulmonary symptoms. In a small
prior study, we found the rate of MI to be the same (about
30%) for LBBB patients presenting to an emergency de-
partment with acute chest pain or with acute onset of
dyspnea (9). Since the patients without chest pain have a
comparable or higher mortality rate compared with those
with chest pain, they should be identified as high risk and
treated aggressively with the presumed diagnosis of MI.
The uniqueness of this study is the attention to the
multiple processes of care that affect survival in patients with
LBBB. No prior study has systematically evaluated the
diagnosis and treatment in-hospital of a community based
sample of patients with MI presenting with LBBB. The
sample size of 29,585 and the distribution of patients across
the country allowed us sufficient power to make definitive
conclusions about the current treatment of MI patients with
LBBB in the U.S.
Study limitations. The major weakness of this study is its
reliance on chart abstraction. We did not interview patients
with LBBB to determine the presence and character of their
chest, arm or throat discomfort. However, misclassification
bias (i.e., presence of chest pain not recorded in the medical
record) should have diminished any differences we observed.
Our observation period is limited to the hospitalization, so
we cannot make conclusions about longer-term outcomes of
these patients. We also excluded patients who were trans-
ferred in or out of the participating hospitals, which could
have biased our results if these patients were systematically
different from LBBB patients who were not transferred. We
do not know what proportion of the LBBBs were “new” or
“old”; this characterization could have confounded the
association between chest pain and survival, if patients
without chest pain were more likely to have “new” LBBB.
Lastly, our data set includes only patients who met criteria
for MI. We do not have data on patients who were admitted
for cardiopulmonary symptoms but did not have MI.
Conclusions. In conclusion, we found LBBB patients with
MI presenting without chest pain were less likely to be
diagnosed with MI, less likely to receive appropriate med-
ications and reperfusion therapy and more likely to die
in-hospital. The mortality difference between patients with
and without chest pain was primarily explained by more
Figure 1. The association of the absence of chest pain with in-hospital
mortality after myocardial infarction in patients with left bundle branch
block. The mortality risk associated with the absence of chest pain is
calculated in a series of multivariate adjustments. Model 1 is adjusted for
differences in patient demographic characteristics and past medical history.
Model 2 includes variables from Model 1 and adds severity of illness
characteristics. Model 3 adjusts for the above variables, hospital bed
assignment and medications and procedures received in-hospital.
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complicated MIs in patients without chest pain and better
treatment of patients with chest pain.
Physicians and hospitals should develop strategies for the
rapid recognition and treatment of all LBBB patients who
present with cardiopulmonary symptoms. These strategies
could include the following: 1) educating physicians of the
high prevalence of atypical symptoms in LBBB patients
with MI and their elevated case-fatality rate, 2) improved
implementation of evidenced-based guidelines for medical
treatment of MI in patients with LBBB, such as aspirin,
beta-blockers and ACE inhibitors, and 3) consideration of
urgent reperfusion in LBBB patients with symptoms con-
sistent with MI.
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